About the Tumour Virus Session
Tumor viruses, also known as oncogenic viruses, are a fascinating area of cancer research. These viruses have the ability to manipulate cellular machinery, leading to uncontrolled cell growth and potentially tumorigenesis. One prominent example is the human papillomavirus (HPV), implicated in cervical and other cancers.
These viruses carry specific genes or proteins that can interfere with cellular regulation, promoting cell division and inhibiting cell death pathways. Understanding the intricate mechanisms by which tumor viruses operate provides crucial insights into cancer biology and potential therapeutic targets. Research into tumor viruses not only sheds light on viral oncogenesis but also offers avenues for developing vaccines and antiviral therapies to prevent or treat virus-induced cancers. By deciphering the complex interplay between viruses and host cells, scientists strive to unravel the mysteries of cancer and pave the way for more effective treatments.
Topics Covered in Tumour Virus
Human Papillomavirus
Hepatitis Viruses
Oncogenic Herpesviruses
Retroviral Oncogenes
Viral Oncoproteins
HPV & HBV Vaccines
Related Scientific Sessions at CIOC 2027
Why Attend the Tumour Virus Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Tumour Virus work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Tumour Virus research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Tumour Virus track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Tumour Virus Conference 2027 — FAQs
What is the Tumour Virus track at CIOC 2027?
The Tumour Virus track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Tumour Virus. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Tumour Virus sessions?
Cancer researchers and clinicians, educators and students with an interest in Tumour Virus are all welcome — whether presenting or attending.
Can I present my research in the Tumour Virus track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Tumour Virus sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Tumour Virus track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.